These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25326383)

  • 1. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M
    J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A
    J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284.
    Smith DL; Davoren JE; Edgerton JR; Lazzaro JT; Lee CW; Neal S; Zhang L; Grimwood S
    Mol Pharmacol; 2016 Sep; 90(3):177-87. PubMed ID: 27382013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.
    Yeatman HR; Lane JR; Choy KH; Lambert NA; Sexton PM; Christopoulos A; Canals M
    J Biol Chem; 2014 May; 289(22):15856-66. PubMed ID: 24753247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M
    Jörg M; van der Westhuizen ET; Khajehali E; Burger WAC; White JM; Choy KHC; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ
    ACS Chem Neurosci; 2019 Mar; 10(3):1099-1114. PubMed ID: 30547573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
    van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
    Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacologic characterization of allosteric molecules: Gq protein activation.
    Bdioui S; Verdi J; Pierre N; Trinquet E; Roux T; Kenakin T
    J Recept Signal Transduct Res; 2019 Apr; 39(2):106-113. PubMed ID: 31322035
    [No Abstract]   [Full Text] [Related]  

  • 11. A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation.
    Canals M; Lane JR; Wen A; Scammells PJ; Sexton PM; Christopoulos A
    J Biol Chem; 2012 Jan; 287(1):650-659. PubMed ID: 22086918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
    Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring Agonist Function at a Chemogenetically Modified M
    Khajehali E; Bradley S; van der Westhuizen ET; Molloy C; Valant C; Finlayson L; Lindsley CW; Sexton PM; Tobin AB; Christopoulos A
    ACS Chem Neurosci; 2020 Dec; 11(24):4270-4279. PubMed ID: 33196174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.
    Choy KH; Shackleford DM; Malone DT; Mistry SN; Patil RT; Scammells PJ; Langmead CJ; Pantelis C; Sexton PM; Lane JR; Christopoulos A
    J Pharmacol Exp Ther; 2016 Nov; 359(2):354-365. PubMed ID: 27630144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
    Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
    J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor.
    Avlani VA; Langmead CJ; Guida E; Wood MD; Tehan BG; Herdon HJ; Watson JM; Sexton PM; Christopoulos A
    Mol Pharmacol; 2010 Jul; 78(1):94-104. PubMed ID: 20413650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
    Shirey JK; Brady AE; Jones PJ; Davis AA; Bridges TM; Kennedy JP; Jadhav SB; Menon UN; Xiang Z; Watson ML; Christian EP; Doherty JJ; Quirk MC; Snyder DH; Lah JJ; Levey AI; Nicolle MM; Lindsley CW; Conn PJ
    J Neurosci; 2009 Nov; 29(45):14271-86. PubMed ID: 19906975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bitopic Binding Mode of an M
    Bradley SJ; Molloy C; Bundgaard C; Mogg AJ; Thompson KJ; Dwomoh L; Sanger HE; Crabtree MD; Brooke SM; Sexton PM; Felder CC; Christopoulos A; Broad LM; Tobin AB; Langmead CJ
    Mol Pharmacol; 2018 Jun; 93(6):645-656. PubMed ID: 29695609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.